From Earlier: Covidien Announces FDA 510k Clearance and CE Mark for Nellcor Bedside Respiratory Patient Monitoring System

by Paul Quintaro, Benzinga Editor
October 4, 2012 10:07 AM | 15 seconds read | Make a Comment
Loading...
Loading...
Covidien
COV
, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced U.S. Food and Drug Administration 510(k) clearance and European Economic Area (EEA) CE Mark approval for the Covidien Nellcor^™ Bedside Respiratory Patient Monitoring system.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted In: NewsFDA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!